Latest News about AMGN
Recent news which mentions AMGN
3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade
August 20, 2025
From Motley Fool
Warren Buffett, Cathie Wood Share 2 Stock Investments In Common: Can You Guess What They Are?
August 18, 2025
From Benzinga
Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS
August 16, 2025
From Benzinga
From Motley Fool
Amgen Stock Sinks As Market Eyes MariTide's Next Move
August 06, 2025
From Benzinga
Wall Street Recovers, Apple Rallies 6% On $100-Billion Gov Manufacturing Investment: What's Moving Markets Wednesday?
August 06, 2025
From Benzinga
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
August 06, 2025
From Benzinga
Trump Threatens Pharma With Potential 250% Tariffs In 18 Months: 'We Want Pharmaceuticals Made In Our Country'
August 06, 2025
From Benzinga
Small-Caps Stay Higher, Other Indexes Dwindle
August 06, 2025
From TalkMarkets
Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday?
August 05, 2025
From Benzinga
Stock Market Today: US Stock Futures Inch Higher, As Analysts Warn of Volatile August—AMD, Pfizer, Caterpillar In Focus
August 05, 2025
From Benzinga
Earnings Scheduled For August 5, 2025
August 05, 2025
From Benzinga
Selloff? What Selloff? Monday Market Rebound
August 04, 2025
From TalkMarkets
Nuclear Threats, Trump Fires Labor Statistics Chief, Fed Governor Resigns And More: This Week In Politics
August 03, 2025
From Benzinga
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
August 01, 2025
From Benzinga
From Benzinga
2 Top Dividend Stocks to Buy Right Now and Hold Forever
July 28, 2025
From Motley Fool
AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
July 24, 2025
From Benzinga
How Does Nvidia's Reaching $4 Trillion in Market Cap Impact the S&P 500, Nasdaq-100, and Dow Jones?
July 14, 2025
From Motley Fool
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
July 11, 2025
From Benzinga
From Benzinga
From Benzinga
From TalkMarkets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.